Nice-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

wniewnie
2022-04-07

Nice

Pfizer To Buy RSV Drug Developer ReViral For Up To $525 Million

(Reuters) -Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as mu

Pfizer To Buy RSV Drug Developer ReViral For Up To $525 Million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

Dawang
·2022-04-07
Agreed, good stuff and good price!
Reply
Like
Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9012249269,"tweetId":"9012249269","gmtCreate":1649343446631,"gmtModify":1676534495164,"author":{"id":4095228411424310,"idStr":"4095228411424310","authorId":4095228411424310,"authorIdStr":"4095228411424310","name":"wniewnie","avatar":"https://community-static.tradeup.com/news/25dcbc454266cc0710cc81103ccaa391","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.25","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9012249269","repostId":2225459005,"repostType":2,"repost":{"id":"2225459005","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1649331084,"share":"https://www.laohu8.com/m/news/2225459005?lang=&edition=full","pubTime":"2022-04-07 19:31","market":"us","language":"en","title":"Pfizer To Buy RSV Drug Developer ReViral For Up To $525 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2225459005","media":"Reuters","summary":"(Reuters) -Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as mu","content":"<html><head></head><body><p>(Reuters) -<a href=\"https://laohu8.com/S/PFE\">Pfizer Inc</a> said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million, including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus (RSV).</p><p>London-based Reviral has four RSV therapies in its pipeline, with two currently in mid-stage studies, including its lead product candidate sisunatovir.</p><p>The deal marks the U.S. drugmaker&#39;s second acquisition in less than six months to enhance its drug portfolio. Pfizer acquired Arena Pharmaceuticals in a deal worth $6.7 billion in December, adding a promising bowel disease treatment to its ranks.</p><p>RSV is a common respiratory virus that causes symptoms similar to those of a cold. It is a common cause of pneumonia in toddlers and the elderly.</p><p>According to analytics firm GlobalData, the RSV prevention market is expected to grow fourteen-fold to $6.3 bln by 2030 from 2020, making it a lucrative market for drugmakers globally.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer To Buy RSV Drug Developer ReViral For Up To $525 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer To Buy RSV Drug Developer ReViral For Up To $525 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-04-07 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>(Reuters) -<a href=\"https://laohu8.com/S/PFE\">Pfizer Inc</a> said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million, including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus (RSV).</p><p>London-based Reviral has four RSV therapies in its pipeline, with two currently in mid-stage studies, including its lead product candidate sisunatovir.</p><p>The deal marks the U.S. drugmaker&#39;s second acquisition in less than six months to enhance its drug portfolio. Pfizer acquired Arena Pharmaceuticals in a deal worth $6.7 billion in December, adding a promising bowel disease treatment to its ranks.</p><p>RSV is a common respiratory virus that causes symptoms similar to those of a cold. It is a common cause of pneumonia in toddlers and the elderly.</p><p>According to analytics firm GlobalData, the RSV prevention market is expected to grow fourteen-fold to $6.3 bln by 2030 from 2020, making it a lucrative market for drugmakers globally.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4581":"高盛持仓","BK4007":"制药","PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2225459005","content_text":"(Reuters) -Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million, including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus (RSV).London-based Reviral has four RSV therapies in its pipeline, with two currently in mid-stage studies, including its lead product candidate sisunatovir.The deal marks the U.S. drugmaker's second acquisition in less than six months to enhance its drug portfolio. Pfizer acquired Arena Pharmaceuticals in a deal worth $6.7 billion in December, adding a promising bowel disease treatment to its ranks.RSV is a common respiratory virus that causes symptoms similar to those of a cold. It is a common cause of pneumonia in toddlers and the elderly.According to analytics firm GlobalData, the RSV prevention market is expected to grow fourteen-fold to $6.3 bln by 2030 from 2020, making it a lucrative market for drugmakers globally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":772,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":101097717,"commentId":"101097717","gmtCreate":1649346718711,"gmtModify":1663246350538,"authorId":3579482809178950,"author":{"id":3579482809178950,"idStr":"3579482809178950","authorId":3579482809178950,"name":"Dawang","avatar":"https://static.tigerbbs.com/d0f01f2346125f600328ffd48beb3a4c","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.07%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9012249269,"objectIdStr":"9012249269","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Agreed, good stuff and good price!","text":"Agreed, good stuff and good price!","html":"Agreed, good stuff and good price!","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}